ArticleFrontiers in pharmacology2023

Mesenchymal stem cells elicits Anti-PD1 immunotherapy by targeted delivery of CX3CL1.

Jize Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.